Comparative irritancy study among retinoid creams and gels

Journal of Cutaneous Medicine and Surgery

Volumn 3, Issue 6, 1999, Pages 298-301

  Toole, J W P ^a   Lockhart, Leslie ^a   Potrebka, Joelle ^a   Bowman, James P ^a   Novack, Gary D ^b  

^a Hill Top Research   (Canada)

^b PHARMALOGIC DEVELOPMENT INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; DODECYL SULFATE SODIUM; PETROLATUM; REJUVA A; RETINOIC ACID; RETINOID; RETISOL A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION;

EID: 0032831416     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347549900300604     Document Type: Article

References (13)

1. Kligman A. Topical tretinoin: indications, safety, and effectiveness. Cutis 1987; 39:486-488.
2. Shalita A, Weiss JS, Chalker DK, et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. J Am Acad Dermatol 1996; 34:482-485.
3. Verschoore M, Poncet M, Czernielewski J, et al. Adapalene 0.1% gel has low skin-irritation potential. J Am Acad Dermatol 1997; 36:S104-S109.
4. Caron D, Sorba V, Kerrouche N, Clucas A. Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients. J Am Acad Dermatol 1997; 36:S110-S112.
5. Griffiths CE, Kang S, Ellis CN, et al. Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. A double-blind, vehicle-controlled comparison of 0.1% and 0.025% tretinoin creams. Arch Dermatol 1995; 131:1037-1044.
6. Katsambas A, Graupe K, Stratigos J. Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin. Acta Derm Venereol Suppl (Stockh) 1989; 143:35-39.
7. Lanman BM, Elvers EB, Howard CJ. The role of human patch testing in a product development program. Joint Conference on Cosmetic Sciences, The Toilet Goods Association (currently The Cosmetic, Toiletry and Fragrance Association), Washington DC, April 21-23. 1968.
8. Phillips L, Steinberg M, Maibach HI, Akers WA. A comparison of rabbit and human skin response to certain irritants. Toxicol Appl Pharmacol 1972; 21:369-382.
9. Berger RS, Bowman JP. A reappraisal of the 21-day cumulative irritation test in man. J Toxicol Cutaneous Ocular 1982; 1:109-115.
10. Conover WJ. Practical non-parametric statistics. New York: John Wiley & Sons, 1980:299-305.
11. Brogden RN, Goa KE, Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs 1997; 53:511-519.
12. Clucas A, Verschoore M, Sorba V, et al. Adapalene 0.1% gel is better tolerated than tretinoin 0.025% gel in acne patients. J Am Acad Dermatol 1997; 36:S116-S118.
13. Cunliffe WJ, Caputo R, Dreno B, et al. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials. J Am Acad Dermatol 1997; 36:5126-5134.